Stockreport

Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis

PROTEOSTASIS THERAPEUTICS  (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
PDF CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discover [Read more]